A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms

Autor: Lorenz Trümper, Sylvia Hartmann, Reiner Siebert, Eliza Wickham-Garcia, Julia Richter, Martin J. S. Dyer, Martin Dreyling, María José Calasanz, Marc Seifert, José I. Martín-Subero, Jian-Bing Fan, Harald Stein, Wolfram Klapper, Javier Suela, Ralf Küppers, Marina Bibikova, Martina Deckert, Jose Roman-Gomez, Jan Dürig, Inga Nagel, Stefanie Bug, Ole Ammerpohl, Christiane Pott, Inga Vater, Felipe Prosper, Monika Brüggemann, Juan C. Cigudosa, Ming Q. Du, Stefan Gesk, Claudia Haferlach, Manuel Montesinos-Rongen, Martin-Leo Hansmann, Sara Alvarez, Lana Harder, Xabier Agirre
Přispěvatelé: Universitat de Barcelona
Rok vydání: 2009
Předmět:
Candidate gene
Myeloid
T-Lymphocytes
ADN
lcsh:Medicine
0302 clinical medicine
Cluster Analysis
lcsh:Science
Oncology/Hematological Malignancies
Promoter Regions
Genetic

Oligonucleotide Array Sequence Analysis
Genetics
B-Lymphocytes/metabolism
CpG Islands
DNA Methylation
Gene Expression Profiling
Hematologic Neoplasms/genetics
Hematologic Neoplasms/metabolism
Humans
Oligonucleotide Array Sequence Analysis/methods
Promoter Regions
Genetic
T-Lymphocytes/metabolism
0303 health sciences
B-Lymphocytes
Multidisciplinary
medicine.anatomical_structure
CpG site
Cèl·lules T
030220 oncology & carcinogenesis
Hematologic Neoplasms
DNA methylation
Hematology/Lymphomas and Chronic Lymphoblastic Leukemia
Ciencias de la Salud::Oncología [Materias Investigacion]
Research Article
Cèl·lules B
T cells
Biology
03 medical and health sciences
Genetics and Genomics/Epigenetics
medicine
Epigenetics
ddc:610
Gene
Genetics and Genomics/Cancer Genetics
030304 developmental biology
B cells
lcsh:R
Promoter
DNA
Expressió gènica
Gene expression profiling
Cancer research
lcsh:Q
Gene expression
Zdroj: Dipòsit Digital de la UB
Universidad de Barcelona
PLoS ONE
Recercat. Dipósit de la Recerca de Catalunya
instname
Dadun. Depósito Académico Digital de la Universidad de Navarra
PLoS ONE, Vol 4, Iss 9, p e6986 (2009)
Popis: Background: Alterations in the DNA methylation pattern are a hallmark of leukemias and lymphomas. However, most epigenetic studies in hematologic neoplasms (HNs) have focused either on the analysis of few candidate genes or many genes and few HN entities, and comprehensive studies are required. Methodology/Principal Findings: Here, we report for the first time a microarray-based DNA methylation study of 767 genes in 367 HNs diagnosed with 16 of the most representative B-cell (n = 203), T-cell (n = 30), and myeloid (n = 134) neoplasias, as well as 37 samples from different cell types of the hematopoietic system. Using appropriate controls of B-, T-, or myeloid cellular origin, we identified a total of 220 genes hypermethylated in at least one HN entity. In general, promoter hypermethylation was more frequent in lymphoid malignancies than in myeloid malignancies, being germinal center mature B-cell lymphomas as well as B and T precursor lymphoid neoplasias those entities with highest frequency of geneassociated DNA hypermethylation. We also observed a significant correlation between the number of hypermethylated and hypomethylated genes in several mature B-cell neoplasias, but not in precursor B- and T-cell leukemias. Most of the genes becoming hypermethylated contained promoters with high CpG content, and a significant fraction of them are targets of the polycomb repressor complex. Interestingly, T-cell prolymphocytic leukemias show low levels of DNA hypermethylation and a comparatively large number of hypomethylated genes, many of them showing an increased gene expression. Conclusions/Significance: We have characterized the DNA methylation profile of a wide range of different HNs entities. As well as identifying genes showing aberrant DNA methylation in certain HN subtypes, we also detected six genes—DBC1, DIO3, FZD9, HS3ST2, MOS, and MYOD1—that were significantly hypermethylated in B-cell, T-cell, and myeloid malignancies. These might therefore play an important role in the development of different HNs.
Databáze: OpenAIRE